Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
By leveraging historical analysis and forecast projections, this study offers a holistic understanding of market developments, assisting stakeholders in making informed strategic decisions. Additionally, a SWOT analysis is incorporated to highlight strengths, weaknesses, opportunities, and threats within the sector.
The evolving U.S. tariff policy in 2025 is bringing considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the world, assessing their impacts on Vascular Disrupting Agents market competitiveness, regional economic interdependencies, and supply chain reconfigurations.
Vascular Disrupting Agents Market Segmentation
Market segmentation in research is the process of breaking down a broad market into distinct consumer groups based on shared characteristics, such as demographics, geographic location, behavioral patterns, or lifestyle preferences. This approach enables businesses to refine their product offerings and marketing strategies to better address the unique needs of each segment. By tailoring their approach, companies can optimize resource allocation, enhance customer satisfaction, and drive sales growth, ultimately securing a competitive advantage. Effective segmentation helps businesses gain deeper insights into their audience, craft targeted strategies, and maximize overall market performance.
Vascular Disrupting Agents Market by Type [Analysis by Value from 2020 to ]:
- Tubulin-binding agents
- Flavonoids
- Combretastatin analogs
Vascular Disrupting Agents Market by Application [Analysis by Value from 2020 to ]:
- Oncology
- Anti-angiogenic therapies
- Tumor vascular disruption
Key Players in the Vascular Disrupting Agents Market
Leading market players are focused on strengthening their presence by acquiring emerging companies. Established firms are heavily investing in research and development to introduce innovative products and expand their market reach. Additionally, some companies are engaging in mergers to leverage their combined strengths and deliver high-quality products. Based on these factors, the study includes the following key industry players.
{playerNamesList}
Vascular Disrupting Agents Market Dynamics: Drivers & Restraints
The report meticulously examines the core growth factors and challenges influencing market expansion. Each variable is supported by qualitative and quantitative insights, with Harvey ball indicators representing their level of impact.
Vascular Disrupting Agents Market Analysis & Industry Trends
A comprehensive overview of industry developments, regulatory updates, and structural market shifts is provided. The report also evaluates the impact of U.S. tariff policy on global demand fluctuations and recovery patterns.
Vascular Disrupting Agents Market Size & Demand Forecast ()
Precise market sizing data and demand forecasts are included, covering year-on-year (YoY) growth rates and compound annual growth rate (CAGR) projections, enabling businesses to plan for future growth.
Vascular Disrupting Agents Industry Supply Chain & Competitive Analysis
Using Porter’s Five Forces framework, the report assesses competitive intensity and profitability within the industry. A detailed supply chain analysis examines market participants, operational structures, and efficiency factors.
Vascular Disrupting Agents Segmentation & Growth Forecasts
The study systematically breaks down the Global Vascular Disrupting Agents Market into multiple segments, outlining current conditions and future growth trajectories. This helps identify emerging trends and lucrative opportunities.
Regional Market Insights
The report offers country-wise assessments of market drivers, regulatory frameworks, and growth prospects across key regions:
• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Russia)
• Asia-Pacific (China, India, Japan, South Korea, Australia)
• Rest of the World (Saudi Arabia, Brazil, Nigeria, South Africa)
Competitive Landscape & Key Player Profiles
Detailed evaluations of major companies include:
• Business overview & product offerings
• Financial performance & investment trends
• Recent mergers, acquisitions, and joint ventures (JVs)
• Strategic approaches adopted by market leaders
Executive Summary & Actionable Recommendations
A concise summary featuring charts, infographics, and forward-looking forecasts is provided. The report concludes with strategic recommendations to guide market stakeholders in decision-making.
Why Invest in This Vascular Disrupting Agents Market Report?
✔️ Gain valuable insights into how COVID-19 has influenced the Vascular Disrupting Agents market.
✔️ Discover market opportunities across key global regions.
✔️ Evaluate growth drivers & restraints and their long-term impact.
✔️ Access comprehensive market sizing & forecasting data.
✔️ Stay ahead of industry trends & competitive strategies.
✔️ Monitor M&A activities, partnerships, and joint ventures shaping the market.
For expert insights and customized segmentation, contact us to tailor the report to your specific business needs.
1 Market Overview
1.1 Vascular Disrupting Agents Definition
1.2 Global Vascular Disrupting Agents Market Size and Forecast
1.2.1 By Revenue, Global Vascular Disrupting Agents Market Size, 2019-2030
1.2.2 By Sales Volume, Global Vascular Disrupting Agents Market Size, 2019-2030
1.2.3 Global Vascular Disrupting Agents Price Trend, 2019-2030
1.3 China Vascular Disrupting Agents Market Size and Forecast
1.3.1 By Revenue, China Vascular Disrupting Agents Market Size, 2019-2030
1.3.2 By Sales Volume, China Vascular Disrupting Agents Market Size, 2019-2030
1.3.3 China Vascular Disrupting Agents Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Vascular Disrupting Agents Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China Vascular Disrupting Agents Share in Global Market, 2019-2030
1.4.3 Vascular Disrupting Agents Market Size: China VS Global, 2019-2030
1.5 Vascular Disrupting Agents Market Dynamics
1.5.1 Vascular Disrupting Agents Market Drivers
1.5.2 Vascular Disrupting Agents Market Restraints
1.5.3 Vascular Disrupting Agents Industry Trends
1.5.4 Vascular Disrupting Agents Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Vascular Disrupting Agents Revenue by Company, 2019-2023
2.2 Global Vascular Disrupting Agents Sales Volume by Company, 2019-2023
2.3 Global Vascular Disrupting Agents Price by Company, 2019-2023
2.4 Global Vascular Disrupting Agents Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Vascular Disrupting Agents Concentration Ratio
2.6 Global Vascular Disrupting Agents Mergers & Acquisitions, Expansion Plans
2.7 Global Vascular Disrupting Agents Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Vascular Disrupting Agents Revenue by Company, 2019-2023
3.2 China Vascular Disrupting Agents Sales Volume by Company, 2019-2023
3.3 China Vascular Disrupting Agents Vascular Disrupting Agents Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Vascular Disrupting Agents Market, Sales Percentage of Local Players VS Foreign Players (2019-2023)
3.5 Chinese Local Players, Vascular Disrupting Agents Domestic VS Export
3.6 China Market, Vascular Disrupting Agents Import & Export
3.6.1 China Market, Vascular Disrupting Agents Import & Export, 2019-2030
3.6.2 China Vascular Disrupting Agents Import & Export Trends
3.6.3 Main Sources of China Vascular Disrupting Agents Import
3.6.4 Export Destination of China Vascular Disrupting Agents
4 Vascular Disrupting Agents Production by Region
4.1 Global Vascular Disrupting Agents Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of Vascular Disrupting Agents Manufacturers
4.3 Global Major Manufacturers, Vascular Disrupting Agents Capacity Expansion and Future Plans
4.4 Global Vascular Disrupting Agents Capacity by Region
4.5 Global Vascular Disrupting Agents Production by Region
4.5.1 Global Vascular Disrupting Agents Production & Forecast by Region, 2019 VS 2023 VS 2030
4.5.2 Global Vascular Disrupting Agents Production by Region, 2019-2023
4.5.3 Global Vascular Disrupting Agents Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Vascular Disrupting Agents Industry Chain
5.2 Vascular Disrupting Agents Upstream Analysis
5.2.1 Vascular Disrupting Agents Core Raw Materials
5.2.2 Main Manufacturers of Vascular Disrupting Agents Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Vascular Disrupting Agents Production Mode
5.6 Vascular Disrupting Agents Procurement Model
5.7 Vascular Disrupting Agents Industry Sales Model and Sales Channels
5.7.1 Vascular Disrupting Agents Sales Model
5.7.2 Vascular Disrupting Agents Typical Distributors
6 Sights by Type
6.1 Vascular Disrupting Agents Classification
6.1.1 Oral
6.1.2 Vein
6.2 By Type, Global Vascular Disrupting Agents Market Size & CAGR, 2019 VS 2023 VS 2030
6.3 By Type, Global Vascular Disrupting Agents Revenue, 2019-2030
6.4 By Type, Global Vascular Disrupting Agents Sales Volume, 2019-2030
6.5 By Type, Global Vascular Disrupting Agents Price, 2019-2030
7 Sights by Application
7.1 Vascular Disrupting Agents Segment by Application
7.1.1 Hospital
7.1.2 Specialty Clinic
7.1.3 Others
7.2 By Application, Global Vascular Disrupting Agents Market Size & CAGR, 2019 VS 2023 VS 2030
7.3 By Application, Global Vascular Disrupting Agents Revenue, 2019-2030
7.4 By Application, Global Vascular Disrupting Agents Sales Volume, 2019-2030
7.5 By Application, Global Vascular Disrupting Agents Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Vascular Disrupting Agents Market Size, 2019 VS 2023 VS 2030
8.2 By Region, Global Vascular Disrupting Agents Revenue, 2019-2030
8.3 By Region, Global Vascular Disrupting Agents Sales Volume, 2019-2030
8.4 North America
8.4.1 North America Vascular Disrupting Agents Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America Vascular Disrupting Agents Market Size Market Share
8.5 Europe
8.5.1 Europe Vascular Disrupting Agents Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Vascular Disrupting Agents Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Vascular Disrupting Agents Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Vascular Disrupting Agents Market Size Market Share
8.7 South America
8.7.1 South America Vascular Disrupting Agents Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Vascular Disrupting Agents Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Vascular Disrupting Agents Market Size & CAGR,2019 VS 2023 VS 2030
9.2 By Country, Global Vascular Disrupting Agents Revenue, 2019-2030
9.3 By Country, Global Vascular Disrupting Agents Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S. Vascular Disrupting Agents Market Size, 2019-2030
9.4.2 By Company, U.S. Vascular Disrupting Agents Sales Volume Market Share, 2023
9.4.3 By Type, U.S. Vascular Disrupting Agents Market Size, Share, 2023 VS 2030
9.4.4 By Application, U.S. Vascular Disrupting Agents Market Size, Share, 2023 VS 2030
9.5 Europe
9.5.1 Europe Vascular Disrupting Agents Market Size, 2019-2030
9.5.2 By Company, Europe Vascular Disrupting Agents Sales Volume Market Share, 2023
9.5.3 By Type, Europe Vascular Disrupting Agents Market Size, Share, 2023 VS 2030
9.5.4 By Application, Europe Vascular Disrupting Agents Market Size, Share, 2023 VS 2030
9.6 China
9.6.1 China Vascular Disrupting Agents Market Size, 2019-2030
9.6.2 By Company, China Vascular Disrupting Agents Sales Volume Market Share, 2023
9.6.3 By Type, China Vascular Disrupting Agents Market Size, Share, 2023 VS 2030
9.6.4 By Application, China Vascular Disrupting Agents Market Size, Share, 2023 VS 2030
9.7 Japan
9.7.1 Japan Vascular Disrupting Agents Market Size, 2019-2030
9.7.2 By Company, Japan Vascular Disrupting Agents Sales Volume Market Share, 2023
9.7.3 By Type, Japan Vascular Disrupting Agents Market Size, Share, 2023 VS 2030
9.7.4 By Application, Japan Vascular Disrupting Agents Market Size, Share, 2023 VS 2030
9.8 South Korea
9.8.1 South Korea Vascular Disrupting Agents Market Size, 2019-2030
9.8.2 By Company, South Korea Vascular Disrupting Agents Sales Volume Market Share, 2023
9.8.3 By Type, South Korea Vascular Disrupting Agents Market Size, Share, 2023 VS 2030
9.8.4 By Application, South Korea Vascular Disrupting Agents Market Size, Share, 2023 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia Vascular Disrupting Agents Market Size, 2019-2030
9.9.2 By Company, Southeast Asia Vascular Disrupting Agents Sales Volume Market Share, 2023
9.9.3 By Type, Southeast Asia Vascular Disrupting Agents Market Size, Share, 2023 VS 2030
9.9.4 By Application, Southeast Asia Vascular Disrupting Agents Market Size, Share, 2023 VS 2030
9.10 India
9.10.1 India Vascular Disrupting Agents Market Size, 2019-2030
9.10.2 By Company, India Vascular Disrupting Agents Sales Volume Market Share, 2023
9.10.3 By Type, India Vascular Disrupting Agents Market Size, Share, 2023 VS 2030
9.10.4 By Application, India Vascular Disrupting Agents Market Size, Share, 2023 VS 2030
9.11 Middle East & Asia
9.11.1 Middle East & Asia Vascular Disrupting Agents Market Size, 2019-2030
9.11.2 By Company, Middle East & Asia Vascular Disrupting Agents Sales Volume Market Share, 2023
9.11.3 By Type, Middle East & Asia Vascular Disrupting Agents Market Size, Share, 2023 VS 2030
9.11.4 By Application, Middle East & Asia Vascular Disrupting Agents Market Size, Share, 2023 VS 2030
10 Manufacturers Profile
10.1 AGC Biologics
10.1.1 AGC Biologics Company Information, Head Office, Market Area and Industry Position
10.1.2 AGC Biologics Vascular Disrupting Agents Models, Specifications and Application
10.1.3 AGC Biologics Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.1.4 AGC Biologics Company Profile and Main Business
10.1.5 AGC Biologics Recent Developments
10.2 Avid Bioservices
10.2.1 Avid Bioservices Company Information, Head Office, Market Area and Industry Position
10.2.2 Avid Bioservices Vascular Disrupting Agents Models, Specifications and Application
10.2.3 Avid Bioservices Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.2.4 Avid Bioservices Company Profile and Main Business
10.2.5 Avid Bioservices Recent Developments
10.3 Bionomics
10.3.1 Bionomics Company Information, Head Office, Market Area and Industry Position
10.3.2 Bionomics Vascular Disrupting Agents Models, Specifications and Application
10.3.3 Bionomics Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.3.4 Bionomics Company Profile and Main Business
10.3.5 Bionomics Recent Developments
10.4 Beijing Shenogen Biomedical
10.4.1 Beijing Shenogen Biomedical Company Information, Head Office, Market Area and Industry Position
10.4.2 Beijing Shenogen Biomedical Vascular Disrupting Agents Models, Specifications and Application
10.4.3 Beijing Shenogen Biomedical Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.4.4 Beijing Shenogen Biomedical Company Profile and Main Business
10.4.5 Beijing Shenogen Biomedical Recent Developments
10.5 Mateon Therapeutics
10.5.1 Mateon Therapeutics Company Information, Head Office, Market Area and Industry Position
10.5.2 Mateon Therapeutics Vascular Disrupting Agents Models, Specifications and Application
10.5.3 Mateon Therapeutics Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.5.4 Mateon Therapeutics Company Profile and Main Business
10.5.5 Mateon Therapeutics Recent Developments
10.6 Myrexis
10.6.1 Myrexis Company Information, Head Office, Market Area and Industry Position
10.6.2 Myrexis Vascular Disrupting Agents Models, Specifications and Application
10.6.3 Myrexis Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.6.4 Myrexis Company Profile and Main Business
10.6.5 Myrexis Recent Developments
10.7 VBL Therapeutics
10.7.1 VBL Therapeutics Company Information, Head Office, Market Area and Industry Position
10.7.2 VBL Therapeutics Vascular Disrupting Agents Models, Specifications and Application
10.7.3 VBL Therapeutics Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.7.4 VBL Therapeutics Company Profile and Main Business
10.7.5 VBL Therapeutics Recent Developments
10.8 Steba biotech
10.8.1 Steba biotech Company Information, Head Office, Market Area and Industry Position
10.8.2 Steba biotech Vascular Disrupting Agents Models, Specifications and Application
10.8.3 Steba biotech Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.8.4 Steba biotech Company Profile and Main Business
10.8.5 Steba biotech Recent Developments
10.9 BeyondSpring Pharmaceutical
10.9.1 BeyondSpring Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.9.2 BeyondSpring Pharmaceutical Vascular Disrupting Agents Models, Specifications and Application
10.9.3 BeyondSpring Pharmaceutical Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.9.4 BeyondSpring Pharmaceutical Company Profile and Main Business
10.9.5 BeyondSpring Pharmaceutical Recent Developments
10.10 Immune Pharmaceuticals
10.10.1 Immune Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.10.2 Immune Pharmaceuticals Vascular Disrupting Agents Models, Specifications and Application
10.10.3 Immune Pharmaceuticals Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.10.4 Immune Pharmaceuticals Company Profile and Main Business
10.10.5 Immune Pharmaceuticals Recent Developments
10.11 Nereus Pharmaceuticals
10.11.1 Nereus Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.11.2 Nereus Pharmaceuticals Vascular Disrupting Agents Models, Specifications and Application
10.11.3 Nereus Pharmaceuticals Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.11.4 Nereus Pharmaceuticals Company Profile and Main Business
10.11.5 Nereus Pharmaceuticals Recent Developments
10.12 Madrigal Pharmaceuticals
10.12.1 Madrigal Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.12.2 Madrigal Pharmaceuticals Vascular Disrupting Agents Models, Specifications and Application
10.12.3 Madrigal Pharmaceuticals Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.12.4 Madrigal Pharmaceuticals Company Profile and Main Business
10.12.5 Madrigal Pharmaceuticals Recent Developments
10.13 Celgene Corporation
10.13.1 Celgene Corporation Company Information, Head Office, Market Area and Industry Position
10.13.2 Celgene Corporation Vascular Disrupting Agents Models, Specifications and Application
10.13.3 Celgene Corporation Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.13.4 Celgene Corporation Company Profile and Main Business
10.13.5 Celgene Corporation Recent Developments
10.14 Bionomics
10.14.1 Bionomics Company Information, Head Office, Market Area and Industry Position
10.14.2 Bionomics Vascular Disrupting Agents Models, Specifications and Application
10.14.3 Bionomics Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.14.4 Bionomics Company Profile and Main Business
10.14.5 Bionomics Recent Developments
10.15 Lees Pharmaceutical Holdings
10.15.1 Lees Pharmaceutical Holdings Company Information, Head Office, Market Area and Industry Position
10.15.2 Lees Pharmaceutical Holdings Vascular Disrupting Agents Models, Specifications and Application
10.15.3 Lees Pharmaceutical Holdings Vascular Disrupting Agents Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.15.4 Lees Pharmaceutical Holdings Company Profile and Main Business
10.15.5 Lees Pharmaceutical Holdings Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
Table 1. Vascular Disrupting Agents Market Size & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Vascular Disrupting Agents Market Restraints
Table 3. Vascular Disrupting Agents Market Trends
Table 4. Vascular Disrupting Agents Industry Policy
Table 5. Global Vascular Disrupting Agents Revenue by Company, 2019-2023, US$ million
Table 6. Global Vascular Disrupting Agents Revenue Market Share by Company, 2019-2023
Table 7. Global Vascular Disrupting Agents Sales Volume by Company, 2019-2023, (K Units)
Table 8. Global Vascular Disrupting Agents Sales Volume Market Share by Company, 2019-2023
Table 9. Global Vascular Disrupting Agents Price by Company, 2019-2023, (US$/Unit)
Table 10. Global Vascular Disrupting Agents Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Vascular Disrupting Agents Mergers & Acquisitions, Expansion Plans
Table 12. Global Vascular Disrupting Agents Manufacturers Product Type
Table 13. China Vascular Disrupting Agents Revenue by Company, 2019-2023, US$ million
Table 14. China Vascular Disrupting Agents Revenue Market Share by Company, 2019-2023
Table 15. China Vascular Disrupting Agents Sales Volume by Company, 2019-2023, (K Units)
Table 16. China Vascular Disrupting Agents Sales Volume Market Share by Company, 2019-2023
Table 17. China Market, Vascular Disrupting Agents Production, Sales, Import and Export, 2019-2030, (K Units)
Table 18. China Vascular Disrupting Agents Import & Export Trends
Table 19. Main Sources of China Vascular Disrupting Agents Import
Table 20. Export Destination of China Vascular Disrupting Agents
Table 21. Global Headquarters and Manufacturing Base of Vascular Disrupting Agents Manufacturers
Table 22. Global Major Manufacturers, Vascular Disrupting Agents Capacity Expansion and Future Plans
Table 23. Global Vascular Disrupting Agents Production & Forecast by Region, 2019 VS 2023 VS 2030, (K Units)
Table 24. Global Vascular Disrupting Agents Production by Region, 2019-2023, (K Units)
Table 25. Global Vascular Disrupting Agents Production Forecast by Region, 2024-2030, (K Units)
Table 26. Global Key Players of Vascular Disrupting Agents Upstream (Raw Materials)
Table 27. Global Vascular Disrupting Agents Typical Customers
Table 28. Vascular Disrupting Agents Typical Distributors
Table 29. By Type, Global Vascular Disrupting Agents Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million
Table 30. By Application, Global Vascular Disrupting Agents Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million
Table 31. By Region, Global Vascular Disrupting Agents Market Size, 2019 VS 2023 VS 2030, US$ Million
Table 32. By Region, Global Vascular Disrupting Agents Revenue, 2019-2030, US$ Million
Table 33. By Region, Global Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)
Table 34. By Country, Global Vascular Disrupting Agents Revenue & CAGR,2019 VS 2023 VS 2030, US$ Million
Table 35. By Country, Global Vascular Disrupting Agents Revenue, 2019-2030, US$ Million
Table 36. By Country, Global Vascular Disrupting Agents Revenue Market Share, 2019-2030
Table 37. By Country, Global Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)
Table 38. By Country, Global Vascular Disrupting Agents Sales Volume Market Share, 2019-2030
Table 39. AGC Biologics Company Information, Head Office, Market Area and Industry Position
Table 40. AGC Biologics Vascular Disrupting Agents Models, Specifications and Application
Table 41. AGC Biologics Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 42. AGC Biologics Company Profile and Main Business
Table 43. AGC Biologics Recent Developments
Table 44. Avid Bioservices Company Information, Head Office, Market Area and Industry Position
Table 45. Avid Bioservices Vascular Disrupting Agents Models, Specifications and Application
Table 46. Avid Bioservices Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 47. Avid Bioservices Company Profile and Main Business
Table 48. Avid Bioservices Recent Developments
Table 49. Bionomics Company Information, Head Office, Market Area and Industry Position
Table 50. Bionomics Vascular Disrupting Agents Models, Specifications and Application
Table 51. Bionomics Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 52. Bionomics Company Profile and Main Business
Table 53. Bionomics Recent Developments
Table 54. Beijing Shenogen Biomedical Company Information, Head Office, Market Area and Industry Position
Table 55. Beijing Shenogen Biomedical Vascular Disrupting Agents Models, Specifications and Application
Table 56. Beijing Shenogen Biomedical Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 57. Beijing Shenogen Biomedical Company Profile and Main Business
Table 58. Beijing Shenogen Biomedical Recent Developments
Table 59. Mateon Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 60. Mateon Therapeutics Vascular Disrupting Agents Models, Specifications and Application
Table 61. Mateon Therapeutics Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 62. Mateon Therapeutics Company Profile and Main Business
Table 63. Mateon Therapeutics Recent Developments
Table 64. Myrexis Company Information, Head Office, Market Area and Industry Position
Table 65. Myrexis Vascular Disrupting Agents Models, Specifications and Application
Table 66. Myrexis Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 67. Myrexis Company Profile and Main Business
Table 68. Myrexis Recent Developments
Table 69. VBL Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 70. VBL Therapeutics Vascular Disrupting Agents Models, Specifications and Application
Table 71. VBL Therapeutics Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 72. VBL Therapeutics Company Profile and Main Business
Table 73. VBL Therapeutics Recent Developments
Table 74. Steba biotech Company Information, Head Office, Market Area and Industry Position
Table 75. Steba biotech Vascular Disrupting Agents Models, Specifications and Application
Table 76. Steba biotech Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 77. Steba biotech Company Profile and Main Business
Table 78. Steba biotech Recent Developments
Table 79. BeyondSpring Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 80. BeyondSpring Pharmaceutical Vascular Disrupting Agents Models, Specifications and Application
Table 81. BeyondSpring Pharmaceutical Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 82. BeyondSpring Pharmaceutical Company Profile and Main Business
Table 83. BeyondSpring Pharmaceutical Recent Developments
Table 84. Immune Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 85. Immune Pharmaceuticals Vascular Disrupting Agents Models, Specifications and Application
Table 86. Immune Pharmaceuticals Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 87. Immune Pharmaceuticals Company Profile and Main Business
Table 88. Immune Pharmaceuticals Recent Developments
Table 89. Nereus Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 90. Nereus Pharmaceuticals Vascular Disrupting Agents Models, Specifications and Application
Table 91. Nereus Pharmaceuticals Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 92. Nereus Pharmaceuticals Company Profile and Main Business
Table 93. Nereus Pharmaceuticals Recent Developments
Table 94. Madrigal Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 95. Madrigal Pharmaceuticals Vascular Disrupting Agents Models, Specifications and Application
Table 96. Madrigal Pharmaceuticals Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 97. Madrigal Pharmaceuticals Company Profile and Main Business
Table 98. Madrigal Pharmaceuticals Recent Developments
Table 99. Celgene Corporation Company Information, Head Office, Market Area and Industry Position
Table 100. Celgene Corporation Vascular Disrupting Agents Models, Specifications and Application
Table 101. Celgene Corporation Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 102. Celgene Corporation Company Profile and Main Business
Table 103. Celgene Corporation Recent Developments
Table 104. Bionomics Company Information, Head Office, Market Area and Industry Position
Table 105. Bionomics Vascular Disrupting Agents Models, Specifications and Application
Table 106. Bionomics Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 107. Bionomics Company Profile and Main Business
Table 108. Bionomics Recent Developments
Table 109. Lees Pharmaceutical Holdings Company Information, Head Office, Market Area and Industry Position
Table 110. Lees Pharmaceutical Holdings Vascular Disrupting Agents Models, Specifications and Application
Table 111. Lees Pharmaceutical Holdings Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 112. Lees Pharmaceutical Holdings Company Profile and Main Business
Table 113. Lees Pharmaceutical Holdings Recent Developments
List of Figure
Figure 1. Vascular Disrupting Agents Picture
Figure 2. By Revenue, Global Vascular Disrupting Agents Market Size and Forecast, 2019-2030, US$ Million
Figure 3. By Sales Volume, Global Vascular Disrupting Agents Market Size and Forecast, 2019-2030, (K Units)
Figure 4. Global Vascular Disrupting Agents Price Trend, 2019-2030, (US$/Unit)
Figure 5. By Revenue, China Vascular Disrupting Agents Market Size and Forecast, 2019-2030, US$ million
Figure 6. By Sales Volume, China Vascular Disrupting Agents Market Size and Forecast, 2019-2030, (K Units)
Figure 7. China Vascular Disrupting Agents Price Trend, 2019-2030 (US$/Unit)
Figure 8. By Revenue, China Vascular Disrupting Agents Share of Global Market, 2019-2030
Figure 9. By Sales Volume, China Vascular Disrupting Agents Share of Global Market, 2019-2030
Figure 10. Global Vascular Disrupting Agents Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 11. Global Vascular Disrupting Agents Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2023
Figure 12. China Vascular Disrupting Agents Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 13. China Vascular Disrupting Agents Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 14. China Vascular Disrupting Agents Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2023
Figure 15. Chinese Local Players, Proportion of Vascular Disrupting Agents Domestic VS Export, 2023
Figure 16. Global Vascular Disrupting Agents Capacity, Production and Capacity Utilization, 2019-2030
Figure 17. Global Vascular Disrupting Agents Capacity Market Share by Region, 2023 VS 2030
Figure 18. Global Vascular Disrupting Agents Production Market Share & Forecast by Region, 2019-2030
Figure 19. Vascular Disrupting Agents Industry Chain
Figure 20. Vascular Disrupting Agents Procurement Model
Figure 21. Vascular Disrupting Agents Sales Model
Figure 22. Vascular Disrupting Agents Sales Channels, Direct Sales and Distribution
Figure 23. Oral
Figure 24. Vein
Figure 25. By Type, Global Vascular Disrupting Agents Revenue, 2019-2030, US$ Million
Figure 26. By Type, Global Vascular Disrupting Agents Revenue Market Share, 2019-2030
Figure 27. By Type, Global Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)
Figure 28. By Type, Global Vascular Disrupting Agents Sales Volume Market Share, 2019-2030
Figure 29. By Type, Global Vascular Disrupting Agents Price, 2019-2030, (US$/Unit)
Figure 30. Hospital
Figure 31. Specialty Clinic
Figure 32. Others
Figure 33. By Application, Global Vascular Disrupting Agents Revenue, 2019-2030, US$ Million
Figure 34. By Application, Global Vascular Disrupting Agents Revenue Market Share, 2019-2030
Figure 35. By Application, Global Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)
Figure 36. By Application, Global Vascular Disrupting Agents Sales Volume Market Share, 2019-2030
Figure 37. By Application, Global Vascular Disrupting Agents Price, 2019-2030, (US$/Unit)
Figure 38. By Region, Global Vascular Disrupting Agents Revenue Market Share, 2019-2030
Figure 39. By Region, Global Vascular Disrupting Agents Sales Volume Market Share, 2019-2030
Figure 40. North America Vascular Disrupting Agents Revenue & Forecasts, 2019-2030, US$ Million
Figure 41. By Country, North America Vascular Disrupting Agents Revenue Market Share, 2023
Figure 42. Europe Vascular Disrupting Agents Revenue & Forecasts, 2019-2030, US$ Million
Figure 43. By Country, Europe Vascular Disrupting Agents Revenue Market Share, 2023
Figure 44. Asia Pacific Vascular Disrupting Agents Revenue & Forecasts, 2019-2030, US$ Million
Figure 45. By Country/Region, Asia Pacific Vascular Disrupting Agents Revenue Market Share, 2023
Figure 46. South America Vascular Disrupting Agents Revenue & Forecasts, 2019-2030, US$ Million
Figure 47. By Country, South America Vascular Disrupting Agents Revenue Market Share, 2023
Figure 48. Middle East & Africa Vascular Disrupting Agents Revenue & Forecasts, 2019-2030, US$ Million
Figure 49. U.S. Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)
Figure 50. By Company, U.S. Vascular Disrupting Agents Market Share, 2023
Figure 51. By Type, U.S. Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030
Figure 52. By Application, U.S. Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030
Figure 53. Europe Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)
Figure 54. By Company, Europe Vascular Disrupting Agents Market Share, 2023
Figure 55. By Type, Europe Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030
Figure 56. By Application, Europe Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030
Figure 57. China Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)
Figure 58. By Company, China Vascular Disrupting Agents Market Share, 2023
Figure 59. By Type, China Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030
Figure 60. By Application, China Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030
Figure 61. Japan Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)
Figure 62. By Company, Japan Vascular Disrupting Agents Market Share, 2023
Figure 63. By Type, Japan Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030
Figure 64. By Application, Japan Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030
Figure 65. South Korea Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)
Figure 66. By Company, South Korea Vascular Disrupting Agents Market Share, 2023
Figure 67. By Type, South Korea Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030
Figure 68. By Application, South Korea Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030
Figure 69. Southeast Asia Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)
Figure 70. By Company, Southeast Asia Vascular Disrupting Agents Market Share, 2023
Figure 71. By Type, Southeast Asia Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030
Figure 72. By Application, Southeast Asia Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030
Figure 73. India Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)
Figure 74. By Company, India Vascular Disrupting Agents Market Share, 2023
Figure 75. By Type, India Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030
Figure 76. By Application, India Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030
Figure 77. Middle East & Asia Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)
Figure 78. By Company, Middle East & Asia Vascular Disrupting Agents Market Share, 2023
Figure 79. By Type, Middle East & Asia Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030
Figure 80. By Application, Middle East & Asia Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030
Figure 81. Research Methodology
Figure 82. Breakdown of Primary Interviews
Figure 83. Bottom-up Approaches
Figure 84. Top-down Approaches
Research Methodology:
Vascular Disrupting Agents Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|